Publication: Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
4
Issued Date
2021-04-15
Resource Type
ISSN
10974172
00928674
00928674
Other identifier(s)
2-s2.0-85103055410
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cell. Vol.184, No.8 (2021), 2201-2211.e7
Suggested Citation
Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, Chang Liu, Alexander J. Mentzer, Helen M. Ginn, Yuguang Zhao, Helen M.E. Duyvesteyn, Rungtiwa Nutalai, Aekkachai Tuekprakhon, Beibei Wang, Guido C. Paesen, Jose Slon-Campos, César López-Camacho, Bassam Hallis, Naomi Coombes, Kevin R. Bewley, Sue Charlton, Thomas S. Walter, Eleanor Barnes, Susanna J. Dunachie, Donal Skelly, Sheila F. Lumley, Natalie Baker, Imam Shaik, Holly E. Humphries, Kerry Godwin, Nick Gent, Alex Sienkiewicz, Christina Dold, Robert Levin, Tao Dong, Andrew J. Pollard, Julian C. Knight, Paul Klenerman, Derrick Crook, Teresa Lambe, Elizabeth Clutterbuck, Sagida Bibi, Amy Flaxman, Mustapha Bittaye, Sandra Belij-Rammerstorfer, Sarah Gilbert, David R. Hall, Mark A. Williams, Neil G. Paterson, William James, Miles W. Carroll, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart, Gavin R. Screaton Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. Vol.184, No.8 (2021), 2201-2211.e7. doi:10.1016/j.cell.2021.02.033 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76208
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Author(s)
Piyada Supasa
Daming Zhou
Wanwisa Dejnirattisai
Chang Liu
Alexander J. Mentzer
Helen M. Ginn
Yuguang Zhao
Helen M.E. Duyvesteyn
Rungtiwa Nutalai
Aekkachai Tuekprakhon
Beibei Wang
Guido C. Paesen
Jose Slon-Campos
César López-Camacho
Bassam Hallis
Naomi Coombes
Kevin R. Bewley
Sue Charlton
Thomas S. Walter
Eleanor Barnes
Susanna J. Dunachie
Donal Skelly
Sheila F. Lumley
Natalie Baker
Imam Shaik
Holly E. Humphries
Kerry Godwin
Nick Gent
Alex Sienkiewicz
Christina Dold
Robert Levin
Tao Dong
Andrew J. Pollard
Julian C. Knight
Paul Klenerman
Derrick Crook
Teresa Lambe
Elizabeth Clutterbuck
Sagida Bibi
Amy Flaxman
Mustapha Bittaye
Sandra Belij-Rammerstorfer
Sarah Gilbert
David R. Hall
Mark A. Williams
Neil G. Paterson
William James
Miles W. Carroll
Elizabeth E. Fry
Juthathip Mongkolsapaya
Jingshan Ren
David I. Stuart
Gavin R. Screaton
Daming Zhou
Wanwisa Dejnirattisai
Chang Liu
Alexander J. Mentzer
Helen M. Ginn
Yuguang Zhao
Helen M.E. Duyvesteyn
Rungtiwa Nutalai
Aekkachai Tuekprakhon
Beibei Wang
Guido C. Paesen
Jose Slon-Campos
César López-Camacho
Bassam Hallis
Naomi Coombes
Kevin R. Bewley
Sue Charlton
Thomas S. Walter
Eleanor Barnes
Susanna J. Dunachie
Donal Skelly
Sheila F. Lumley
Natalie Baker
Imam Shaik
Holly E. Humphries
Kerry Godwin
Nick Gent
Alex Sienkiewicz
Christina Dold
Robert Levin
Tao Dong
Andrew J. Pollard
Julian C. Knight
Paul Klenerman
Derrick Crook
Teresa Lambe
Elizabeth Clutterbuck
Sagida Bibi
Amy Flaxman
Mustapha Bittaye
Sandra Belij-Rammerstorfer
Sarah Gilbert
David R. Hall
Mark A. Williams
Neil G. Paterson
William James
Miles W. Carroll
Elizabeth E. Fry
Juthathip Mongkolsapaya
Jingshan Ren
David I. Stuart
Gavin R. Screaton
Other Contributor(s)
Mahidol Oxford Tropical Medicine Research Unit
NIHR Oxford Biomedical Research Centre
Oxford University Hospitals NHS Foundation Trust
Public Health England
Diamond Light Source
Worthing Hospital
University of Oxford
Sir William Dunn School of Pathology
Faculty of Medicine Siriraj Hospital, Mahidol University
Nuffield Department of Medicine
University of Oxford Medical Sciences Division
Instruct-ERIC
NIHR Oxford Biomedical Research Centre
Oxford University Hospitals NHS Foundation Trust
Public Health England
Diamond Light Source
Worthing Hospital
University of Oxford
Sir William Dunn School of Pathology
Faculty of Medicine Siriraj Hospital, Mahidol University
Nuffield Department of Medicine
University of Oxford Medical Sciences Division
Instruct-ERIC
Abstract
SARS-CoV-2 has caused over 2 million deaths in little over a year. Vaccines are being deployed at scale, aiming to generate responses against the virus spike. The scale of the pandemic and error-prone virus replication is leading to the appearance of mutant viruses and potentially escape from antibody responses. Variant B.1.1.7, now dominant in the UK, with increased transmission, harbors 9 amino acid changes in the spike, including N501Y in the ACE2 interacting surface. We examine the ability of B.1.1.7 to evade antibody responses elicited by natural SARS-CoV-2 infection or vaccination. We map the impact of N501Y by structure/function analysis of a large panel of well-characterized monoclonal antibodies. B.1.1.7 is harder to neutralize than parental virus, compromising neutralization by some members of a major class of public antibodies through light-chain contacts with residue 501. However, widespread escape from monoclonal antibodies or antibody responses generated by natural infection or vaccination was not observed.
